On Wednesday shares of Amgen Inc. (NASDAQ:AMGN) closed at $157.10. Company’s sales growth for last 5 years was 6.50% and EPS growth for next 5 years is recorded as 11.10%. Amgen Inc. (NASDAQ:AMGN) on March 30, 2015, announced that it will present at the Goldman Sachs Key Debates in Biosimilars conference at 9:05 a.m. ET on Thursday, April 2, 2015, at the Goldman Sachs Conference Center in New York City.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) in last trading activity increased 0.80% to close at $105.26. Company weekly performance is 3.42% while its quarterly performance stands at 8.52%. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is -13.67% away from its 52 week high. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) a leading RNAi therapeutics company, announced results from a retrospective natural history study evaluating disease progression in transthyretin (TTR)-mediated amyloidosis (ATTR amyloidosis) patients with familial amyloidotic cardiomyopathy (FAC). Amongst other findings, study results showed a mean decline of 140 meters in 6-minute walk distance (6-MWD) over an 18-month period in FAC patients with mild-to-moderate heart failure.
On last trading day Integrated Device Technology, Inc. (NASDAQ:IDTI) decreased -0.85% to close at $19.85. Its volatility for the week is 3.21% while volatility for the month is 3.36%. IDTI’s sales growth for past 5 years was -6.10% and its EPS growth for past 5 years was 16.20%. Integrated Device Technology, Inc. (NASDAQ:IDTI) monthly performance is -2.26%. Integrated Device Technology, Inc. (NASDAQ:IDTI) announced that it has entered a three-year collaboration with the European Organization for Nuclear Research (CERN) to use IDT’s RapidIO technology to help improve data acquisition and analysis in some of the world’s most advanced fundamental physics research.
DST Systems Inc. (NYSE:DST) has 0.80% insider ownership while its institutional ownership stands at 80.40%. In last trading activity company’s stock closed at $110.58. DST Systems Inc. (NYSE:DST)‘s stock had its “strong-buy” rating restated by Zacks in a research report issued to clients and investors on Friday.
On Wednesday shares of Peabody Energy Corp. (NYSE:BTU) closed at $4.75. Company’s sales growth for last 5 years was 3.00% and EPS growth for next 5 years is recorded as 12.08%. On March 30, 2015, Peabody Energy Corp. (NYSE:BTU) issued a press release announcing the expiration of its previously announced tender offer to purchase for cash any and all of the $650 million aggregate principal amount outstanding of its 7 3/8% Senior Notes due 2016 as specified in the offer to purchase dated March 2, 2015.